Evidence map›Paper›PMID 23211877›Full record

Trial reportMenopause (New York, N.Y.)2013

Effect of soy isoflavone supplementation on menopausal quality of life.

Paula Amato, Ronald L Young, Francene M Steinberg, Michael J Murray, Richard D Lewis, Margaret A Cramer, Stephen Barnes, Kenneth J Ellis, Roman J Shypailo, Joe Kennard Fraley and 5 more

Abstract readMulticenter StudyRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Menopause (New York, N.Y.), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 4 pooled it
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 4 syntheses or guidelines pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Efficacy of Hormonal and Nonhormonal Approaches to Vaginal Atrophy and Sexual Dysfunctions in Postmenopausal Women: A Systematic Review.Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia · 2022
    Pooled it
  3. Pooled it
  4. Phytoestrogens for menopausal vasomotor symptoms.The Cochrane database of systematic reviews · 2013
    Pooled it
  5. Genistein effects on quality of life and depression symptoms in osteopenic postmenopausal women: a 2-year randomized, double-blind, controlled study.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2014
    Trial
  6. Observational
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 1 country.

Paula AmatoOregon Health and Science University, Portland, OR 97239-4501, USA. amatop@ohsu.edu
Ronald L Young
Francene M Steinberg
Michael J Murray
Richard D Lewis
Margaret A Cramer
Stephen Barnes
Kenneth J Ellis
Roman J Shypailo
Joe Kennard Fraley
Karen L Konzelmann
Joan G Fischer
Colette LaSalle
Elliot O'Brian Smith
William W Wong
Baylor College of Medicine · USUniversity of Georgia · USOregon Health & Science University · USUniversity of California, Davis · USKaiser Foundation Hospital · USUniversity of Alabama at Birmingham · US

Funding

ZOLENDRONIC ACID IN CHILDREN W/ SEVERE OSTEOGENESIS IMPERFECTAM01RR000188 · NCRR · BAYLOR COLLEGE OF MEDICINE · PI PLON, SHARON E. · 1985 to 2011
$30.6M
NCRR NIH HHS M01-RR00188
6 · The paper itself

Abstract

objectiveThe purpose of this study was to assess the effect of soy isoflavone supplementation on quality of life in postmenopausal women.

methodsA multicenter, randomized, double-blind, placebo-controlled 24-month trial was conducted to assess the effect of 80 or 120 mg of daily aglycone hypocotyl soy isoflavone supplementation on quality of life in 403 postmenopausal women using a validated Menopause-Specific Quality of Life questionnaire.

resultsMenopause-Specific Quality of Life domain scores at 1 year and 2 years were similar to baseline. There were no differences in domain scores among treatment groups.

conclusionsSoy isoflavone supplementation offers no benefit to quality of life in postmenopausal women.

Indexed as

MenopauseQuality of LifeAdultbeta-GlucansDietary SupplementsDouble-Blind MethodEndometriumFemaleHumansIsoflavonesMiddle AgedPlacebosSurveys and QuestionnairesTreatment OutcomeUltrasonographybeta-GlucansIsoflavonesPlacebossoy isoflavone aglycone

Identifiers

PMID23211877
OpenAlexW2082325056

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.